Drug Patent List
Litigation OpportunitiesNew
Newsletter
Weekly Digest

Pharsight

Paclitaxel Patent Expiration

Paclitaxel is used for treating tumors, breast cancer, lung cancer, and pancreatic cancer. It was first introduced by Hq Specialty Pharma Corp in its drug Taxol on Dec 29, 1992. Other drugs containing Paclitaxel are Paclitaxel, Abraxane. 21 different companies have introduced drugs containing Paclitaxel.


Paclitaxel Patents

Given below is the list of patents protecting Paclitaxel, along with the drug name that holds that patent and the company name owning that drug.

Drug Used in Drug Patent Number Drug Patent Title Drug Patent Expiry Drug Owner
Abraxane US9511046

(Pediatric)

 Methods of treating pancreatic cancer Jul 12, 2034 Bristol-myers
Abraxane US9511046 Methods of treating pancreatic cancer Jan 12, 2034 Bristol-myers
Abraxane US9393318

(Pediatric)

 Methods of treating cancer Sep 04, 2032 Bristol-myers
Abraxane US9597409

(Pediatric)

 Methods of treating cancer Sep 04, 2032 Bristol-myers
Abraxane US9393318 Methods of treating cancer Mar 04, 2032 Bristol-myers
Abraxane US9597409 Methods of treating cancer Mar 04, 2032 Bristol-myers
Abraxane US8034375

(Pediatric)

 Combinations and modes of administration of therapeutic agents and combination therapy Feb 13, 2027 Bristol-myers
Abraxane US7758891

(Pediatric)

 Combinations and modes of administration of therapeutic agents and combination therapy Aug 21, 2026 Bristol-myers
Abraxane US8268348

(Pediatric)

 Combinations and modes of administration of therapeutic agents and combination therapy Aug 21, 2026 Bristol-myers
Abraxane US9101543

(Pediatric)

 Combinations and modes of administration of therapeutic agents and combination therapy Aug 21, 2026 Bristol-myers
Abraxane US8034375 Combinations and modes of administration of therapeutic agents and combination therapy Aug 13, 2026 Bristol-myers
Abraxane US7758891 Combinations and modes of administration of therapeutic agents and combination therapy Feb 21, 2026 Bristol-myers
Abraxane US8268348 Combinations and modes of administration of therapeutic agents and combination therapy Feb 21, 2026 Bristol-myers
Abraxane US9101543 Combinations and modes of administration of therapeutic agents and combination therapy Feb 21, 2026 Bristol-myers
Abraxane US7820788

(Pediatric)

 Compositions and methods of delivery of pharmacological agents Apr 27, 2025

(Expired)

 Bristol-myers
Abraxane US7820788 Compositions and methods of delivery of pharmacological agents Oct 27, 2024

(Expired)

 Bristol-myers
Abraxane US7923536

(Pediatric)

 Compositions and methods of delivery of pharmacological agents Jun 09, 2024

(Expired)

 Bristol-myers
Abraxane US8138229

(Pediatric)

 Compositions and methods of delivery of pharmacological agents Jun 09, 2024

(Expired)

 Bristol-myers
Abraxane US8314156

(Pediatric)

 Compositions and methods of delivery of pharmacological agents Jun 09, 2024

(Expired)

 Bristol-myers
Abraxane US7923536 Compositions and methods of delivery of pharmacological agents Dec 09, 2023

(Expired)

 Bristol-myers
Abraxane US8138229 Compositions and methods of delivery of pharmacological agents Dec 09, 2023

(Expired)

 Bristol-myers
Abraxane US8314156 Compositions and methods of delivery of pharmacological agents Dec 09, 2023

(Expired)

 Bristol-myers
Abraxane US8853260

(Pediatric)

 Formulations of pharmacological agents, methods for the preparation thereof and methods for the use thereof Apr 10, 2021

(Expired)

 Bristol-myers
Abraxane US8853260 Formulations of pharmacological agents, methods for the preparation thereof and methods for the use thereof Oct 10, 2020

(Expired)

 Bristol-myers
Abraxane USRE41884 Reduction of intravenously administered nanoparticulate-formulation-induced adverse physiological reactions Aug 14, 2016

(Expired)

 Bristol-myers
Abraxane US5498421 Composition useful for in vivo delivery of biologics and methods employing same Mar 12, 2013

(Expired)

 Bristol-myers
Abraxane US5439686 Methods for in vivo delivery of substantially water insoluble pharmacologically active agents and compositions useful therefor Feb 22, 2013

(Expired)

 Bristol-myers
Abraxane US6096331 Methods and compositions useful for administration of chemotherapeutic agents Feb 22, 2013

(Expired)

 Bristol-myers
Abraxane US6506405 Methods and formulations of cremophor-free taxanes Feb 22, 2013

(Expired)

 Bristol-myers
Abraxane US6537579 Compositions and methods for administration of pharmacologically active compounds Feb 22, 2013

(Expired)

 Bristol-myers
Abraxane US6749868 Protein stabilized pharmacologically active agents, methods for the preparation thereof and methods for the use thereof Feb 22, 2013

(Expired)

 Bristol-myers
Abraxane US6753006 Paclitaxel-containing formulations Feb 22, 2013

(Expired)

 Bristol-myers



Paclitaxel's Family Patents

Family Patents

Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List

Paclitaxel Generic API Manufacturers

Several generic applications have been filed for Paclitaxel. The first generic version for Paclitaxel was by Teva Pharmaceuticals Usa and was approved on Jan 25, 2002. And the latest generic version is by Hainan Shuangcheng Pharmaceuticals Co Ltd and was approved on May 15, 2025.

Given below is the list of companies who have filed for Paclitaxel generic, along with the locations of their manufacturing plants worldwide.


1. ACCORD HLTHCARE

Accord Healthcare Inc has filed for 1 generic for Paclitaxel. Given below are the details of the strengths of this generic introduced by Accord Hlthcare.

Strength Dosage Form Availability Application Pathway TE code Launch Date
6MG/ML

injectable Prescription INJECTION AP Aug 17, 2018





2. ACTAVIS TOTOWA

Actavis Totowa Llc has filed for 1 generic for Paclitaxel. Given below are the details of the strengths of this generic introduced by Actavis Totowa.

Strength Dosage Form Availability Application Pathway TE code Launch Date
6MG/ML

injectable Prescription INJECTION AP Dec 9, 2009


Manufacturing Plant Locations
New

Actavis Totowa's manufacturing plants are situated in 1 country - United States. Given below are the details of these plant locations as well as the firm names of Actavis Totowa as present at those locations.

Country City Firm Name
United States
Totowa Actavis Totowa LLC
Little Falls Actavis Totowa LLC





3. ALEMBIC

Alembic Pharmaceuticals Ltd has filed for 1 generic for Paclitaxel. Given below are the details of the strengths of this generic introduced by Alembic.

Strength Dosage Form Availability Application Pathway TE code Launch Date
6MG/ML

injectable Prescription INJECTION AP Oct 20, 2022


Manufacturing Plant Locations
New

Alembic's manufacturing plants are situated in 1 country - India. Given below are the details of these plant locations as well as the firm names of Alembic as present at those locations.

Country City Firm Name
India
Vadodara Alembic Pharmaceuticals Limited
Vadodara Alembic Pharmaceuticals Ltd (API Division, Karakhadi)
Vadodara Alembic Pharmaceuticals, Ltd
Panchmahal Alembic Pharmaceuticals Limited (Units I and II)
Panchmahal Alembic Pharmaceuticals Limited
Panelav Alembic Pharmaceuticals Limited
Vadodara Alembic Pharmaceuticals Ltd





4. CIPLA

Cipla Ltd has filed for 1 generic for Paclitaxel. Given below are the details of the strengths of this generic introduced by Cipla.

Strength Dosage Form Availability Application Pathway TE code Launch Date
100MG/VIAL

powder Prescription INTRAVENOUS AB Apr 10, 2025


Manufacturing Plant Locations
New

Cipla's manufacturing plants are situated in 1 country - India. Given below are the details of these plant locations as well as the firm names of Cipla as present at those locations.

Country City Firm Name
India
Raigad Cipla Limited
Pithampur, District Dhar Cipla Limited
Mumbai Cipla Limited
Bengaluru Cipla Limited
Kurkumbh Village, Dist. Pune Cipla, Ltd.
Bangalore Cipla Ltd.
Vasco Da Gama Cipla Limited





5. DASH PHARMS

Dash Pharmaceuticals Llc has filed for 1 generic for Paclitaxel. Given below are the details of the strengths of this generic introduced by Dash Pharms.

Strength Dosage Form Availability Application Pathway TE code Launch Date
6MG/ML

injectable Discontinued INJECTION N/A Sep 29, 2011





6. FRESENIUS KABI USA

Fresenius Kabi Usa Llc has filed for 1 generic for Paclitaxel. Given below are the details of the strengths of this generic introduced by Fresenius Kabi Usa.

Strength Dosage Form Availability Application Pathway TE code Launch Date
6MG/ML

injectable Prescription INJECTION AP Nov 27, 2006


Manufacturing Plant Locations
New

Fresenius Kabi Usa's manufacturing plants are situated in 1 country - United States. Given below are the details of these plant locations as well as the firm names of Fresenius Kabi Usa as present at those locations.

Country City Firm Name
United States
Wilson Fresenius Kabi USA, LLC
Melrose Park Fresenius Kabi USA LLC
Bensenville Fresenius Kabi USA LLC (FK USA)
North Andover Fresenius Kabi USA, LLC
Melrose Park Fresenius Kabi USA, LLC
Lake Zurich Fresenius Kabi USA, LLC
Skokie Fresenius Kabi USA LLC
Grand Island Fresenius Kabi USA, LLC





7. GLAND

Gland Pharma Ltd has filed for 1 generic for Paclitaxel. Given below are the details of the strengths of this generic introduced by Gland.

Strength Dosage Form Availability Application Pathway TE code Launch Date
6MG/ML

injectable Prescription INJECTION AP Aug 23, 2016


Manufacturing Plant Locations
New

Gland's manufacturing plants are situated in 1 country - India. Given below are the details of these plant locations as well as the firm names of Gland as present at those locations.

Country City Firm Name
India
Hyderabad Gland Pharma Limited
Malur Gland Chemicals Pvt Ltd.
Sriperumbudur Gland Chemical Private Limited
Parawada, Visakhapatnam Gland Pharma Limited
Hyderabad Gland Pharma Limited, Units I+II Pashamylaram Site
Aurangabad Gland Chemical Private Limited
Visakhapatnam Gland Pharma Limited





8. HENGRUI PHARMA

Jiangsu Hengrui Pharmaceuticals Co Ltd has filed for 1 generic for Paclitaxel. Given below are the details of the strengths of this generic introduced by Hengrui Pharma.

Strength Dosage Form Availability Application Pathway TE code Launch Date
100MG/VIAL

powder Prescription INTRAVENOUS AB Oct 8, 2024





9. HIKMA

Hikma Pharmaceuticals Usa Inc has filed for 1 generic for Paclitaxel. Given below are the details of the strengths of this generic introduced by Hikma.

Strength Dosage Form Availability Application Pathway TE code Launch Date
6MG/ML

injectable Prescription INJECTION AP Jan 28, 2002


Manufacturing Plant Locations
New

Hikma's manufacturing plants are situated in 3 countries - United States, Portugal, Jordan. Given below are the details of these plant locations as well as the firm names of Hikma as present at those locations.

Country City Firm Name
United States
Cherry Hill Hikma Pharmaceuticals USA Inc.
Carlsbad Hikma Cali Inc. DBA Leucadia Pharmaceuticals
Eatontown Hikma Pharmaceuticals USA, Inc.
Dayton Hikma Injectables USA Inc
Portugal
Terrugem Snt Hikma Farmaceutica, (Portugal) S.A.
Jordan
Amman Hikma Pharmaceuticals LLC





10. HOSPIRA

Hospira Inc has filed for 1 generic for Paclitaxel. Given below are the details of the strengths of this generic introduced by Hospira.

Strength Dosage Form Availability Application Pathway TE code Launch Date
6MG/ML

injectable Discontinued INJECTION N/A Aug 1, 2002


Manufacturing Plant Locations
New

Hospira's manufacturing plants are situated in 3 countries - Australia, United States, Dominican Republic (the). Given below are the details of these plant locations as well as the firm names of Hospira as present at those locations.

Country City Firm Name
Australia
Mulgrave Hospira Australia Pty Ltd.
United States
Lake Forest Hospira Inc
Rocky Mount Hospira, Inc.
Mcpherson Hospira, Inc., A Pfizer Company
Pleasant Prairie Hospira Worldwide, LLC d.b.a. Hospira, a Pfizer-owned Company
Morgan Hill Hospira Inc
Clayton Hospira, Inc.
Dominican Republic (the)
Haina, San Cristobal Hospira, Ltd.





11. MSN

Msn Laboratories Private Ltd has filed for 1 generic for Paclitaxel. Given below are the details of the strengths of this generic introduced by Msn.

Strength Dosage Form Availability Application Pathway TE code Launch Date
6MG/ML

injectable Prescription INJECTION AP Aug 24, 2020


Manufacturing Plant Locations
New

Msn's manufacturing plants are situated in 2 countries - India, United States. Given below are the details of these plant locations as well as the firm names of Msn as present at those locations.

Country City Firm Name
India
Sangareddy MSN Pharmachem Private Limited
Sangareddy MSN Laboratories Private Limited, R&D Center
Yadadri Bhuvanagiri District MSN Organics Private Limited
Kamareddy MSN Life Sciences Private Limited
Jinnaram, Sangareddy MSN Laboratories Private Limited - Formulations Division
Isnapur MSN Laboratories Private Limited, Unit-II
Rangareddy District MSN Laboratories Private Limited
Sangareddy MSN Laboratories Private Ltd.
Rangareddy District MSN Laboratories Private Limited (Formulations Division, Unit-II)
Medak MSN LIFE SCIENCES PRIVATE LIMITED
United States
Piscataway MSN PHARMACEUTICALS INC





12. NORVIUM BIOSCIENCE

Norvium Bioscience Llc has filed for 1 generic for Paclitaxel. Given below are the details of the strengths of this generic introduced by Norvium Bioscience.

Strength Dosage Form Availability Application Pathway TE code Launch Date
6MG/ML

injectable Discontinued INJECTION N/A Jan 25, 2002





13. PLIVA LACHEMA

Pliva Lachema As has filed for 1 generic for Paclitaxel. Given below are the details of the strengths of this generic introduced by Pliva Lachema.

Strength Dosage Form Availability Application Pathway TE code Launch Date
6MG/ML

injectable Discontinued INJECTION N/A Mar 12, 2008





14. SANDOZ

Sandoz Inc has filed for 1 generic for Paclitaxel. Given below are the details of the strengths of this generic introduced by Sandoz.

Strength Dosage Form Availability Application Pathway TE code Launch Date
6MG/ML

injectable Discontinued INJECTION N/A Dec 26, 2007


Manufacturing Plant Locations
New

Sandoz's manufacturing plants are situated in 4 countries - Austria, United States, Spain, India. Given below are the details of these plant locations as well as the firm names of Sandoz as present at those locations.

Country City Firm Name
Austria
Kundl Sandoz GmbH
Langkampfen Sandoz GmbH
United States
East Hanover Sandoz Incorporated
Princeton Sandoz Inc
Spain
Palafolls Sandoz Industrial Products, S.A.
Les Franqueses Del Valles Sandoz Industrial Products S.A.
India
Navi Mumbai Sandoz Private Limited





15. SHUANGCHENG

Hainan Shuangcheng Pharmaceuticals Co Ltd has filed for 1 generic for Paclitaxel. Given below are the details of the strengths of this generic introduced by Shuangcheng.

Strength Dosage Form Availability Application Pathway TE code Launch Date
100MG/VIAL

powder Prescription INTRAVENOUS AB May 15, 2025





16. TEVA PHARMS

Teva Pharmaceuticals Usa has filed for 1 generic for Paclitaxel. Given below are the details of the strengths of this generic introduced by Teva Pharms.

Strength Dosage Form Availability Application Pathway TE code Launch Date
6MG/ML

injectable Prescription INJECTION AP Jan 25, 2002





17. TEVA PHARMS USA

Teva Pharmaceuticals Usa has filed for 1 generic for Paclitaxel. Given below are the details of the strengths of this generic introduced by Teva Pharms Usa.

Strength Dosage Form Availability Application Pathway TE code Launch Date
6MG/ML

injectable Discontinued INJECTION N/A Jan 25, 2002